Author

David Fulkerson

Observed names: DAVID FULKERSON, Fulkerson D

Institution: University of Virginia

Observed institution: University of Virginia

OpenAlex ID: A5118310951

Miniaturized Neural Networks for Deploying Fully Closed Loop Insulin Delivery Systems: A Pilot Study Featuring Flexible Meal Announcement Options

2025 · Elliott C. Pryor, Marcela Moscoso-Vasquez, et al. · Journal of Diabetes Science and Technology · 10

Adults With Type 2 Diabetes Benefit From Automated Insulin Delivery Irrespective of C-Peptide Level

2025 · Irl B. Hirsch, Yogish C. Kudva, et al. · Diabetes Care · 8

Safety and Feasibility of a Fully Automated Insulin Delivery System: FCL@Home, a Multicenter Randomized Clinical Trial in Individuals With Type 1 Diabetes

2025 · Marcela Moscoso-Vasquez, Laya Ekhlaspour, et al. · Diabetes Care · 6

Additive Benefits of Control-IQ+ AID to GLP-1 Receptor Agonist Use in Adults With Type 2 Diabetes

2025 · Timothy E. Graham, Dan Raghinaru, et al. · Diabetes Care · 3

Safety and Feasibility of Algorithmic Continuous Glucose Monitoring-Based Titration in People with Type 2 Diabetes Using Insulin Degludec, With or Without Noninsulin Glucose-Lowering Drugs: A 16-Week Randomized Controlled Trial

2026 · Anas El Fathi, Ralf Nass, et al. · Diabetes Technology & Therapeutics · 1

Automated Insulin Delivery Is Beneficial in Adults With Insulin-Treated Type 2 Diabetes With and Without GAD65 Antibodies

2025 · Roy W. Beck, Irl B. Hirsch, et al. · Diabetes Care · 1

Safety and Feasibility of a Fully Automated Insulin Delivery System: FCL@Home, a Multicenter Randomized Clinical Trial in Individuals With Type 1 Diabetes

2026 · Moscoso-Vasquez M, Ekhlaspour L, et al. · Yearbook of pediatric endocrinology

Safety and Feasibility of a Fully Automated Insulin Delivery System: FCL@Home, a Multicenter Randomized Clinical Trial in Individuals with Type 1 Diabetes

2025 · Marcela Moscoso-Vasquez, Laya Ekhlaspour, et al.

Safety and Feasibility of a Fully Automated Insulin Delivery System: FCL@Home, a Multicenter Randomized Clinical Trial in Individuals with Type 1 Diabetes

2025 · Marcela Moscoso-Vasquez, Laya Ekhlaspour, et al.

919-P: Sex Differences in Glycemic Outcomes Using Fully Automated Closed Loop (FCL) System in Type 1 Diabetes (T1D)—Insights and Implications

2025 · MARCELA MOSCOSO-VASQUEZ, JASMINE Y. HOSSEINIPOUR, et al. · Diabetes

918-P: Fully Closed Loop (FCL) System Improves Glycemic Control through Personalized Adaptation of Individual Insulin Needs in Adults, Young Adults, and Adolescents with Type 1 Diabetes (T1D)

2025 · MARCELA MOSCOSO-VASQUEZ, DILLON FLANAGAN, et al. · Diabetes

Works count: 11

Citation count: 29

H-index: 3

I10-index: 1